Premenstrual Syndrome Treatment Market Size & Trends Report by Type (Prescription, OTC), Product Type (Single Nutritional Supplement, Combined Nutritional Supplement), Drug Type (Analgesics, Antidepressants) & Regional Forecasts to 2030

Request Quote Download FREE Sample
Single User

Table of Contents

  • Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2025-2026)
  • Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  • Executive Summary
    • Premenstrual Syndrome Treatment Market Snapshot (2025-2030)
    • Segment Overview
    • Regional Snapshot
    • Competitive Insights
  • the reproductive-age population
  • Improved diagnostic tools, including hormone tests and symptom-tracking apps
  • Increasing demand for non-invasive and over-the-counter treatments
  • Growing integration of telemedicine services for accessible care
  • Restraints
    • Limited awareness in low-income and rural regions
    • High cost of advanced hormonal therapies and branded medications
    • Potential side effects associated with certain treatments
  • Opportunities
    • Growing acceptance of natural and herbal remedies in mainstream healthcare
    • Development of personalized and targeted therapies for PMS management
  • Key Market Trends
    • Adoption of digital health platforms for symptom tracking and personalized care
    • Increasing popularity of herbal supplements like chasteberry and magnesium
  • Unmet Market Needs
  • Industry Speaks
  • Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Type, USD Million
    • Introduction
    • Prescription
    • OTC
  • Global Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Product, USD Million
    • Introduction
    • Single Nutritional Supplements
      • Vitamins
      • Minerals
      • Herbal Supplements
      • Others
    • Combined Nutritional Supplements
  • Global Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Drug Type, USD Million
    • Introduction
    • Analgesics
    • Antidepressant
    • Pain Relievers
    • Oral Contraceptives
    • Others
  • Global Premenstrual Syndrome Treatment Market Size & Forecast tion Channel, USD Million
    • Introduction
    • Online Sales Channel
    • Direct Sales Channel
    • Pharmacies / Drug Stores
    • Other Channels
  • Global Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Region, USD Million
    • Introduction
    • North America Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Country, USD Million
      • US
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Drug Type (USD Million)
        • Market Size & Forecast, By Distribution Channel (USD Million)
      • Canada
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Million)
        • Market Size &ay Distribution Channel (USD Million)
    • Europe Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Country, USD Million
      • UK
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Drug Type (USD Million)
        • Market Size & Forecast, By Distribution Channel (USD Million)
      • Germany
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Drug Type (USD Million)
        • Market Size & Forecast, By Distribution Channel (USD Million)
      • Italy
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Million)
        • l (USD Million)
      • Spain
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Drug Type (USD Million)
        • Market Size & Forecast, By Distribution Channel (USD Million)
      • Rest of Europe
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Drug Type (USD Million)
        • Market Size & Forecast, By Distribution Channel (USD Million)
    • Asia Pacific (APAC) Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), By Country, USD Million
      • China
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Miannel (USD Million)
      • Japan
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Drug Type (USD Million)
        • Market Size & Forecast, By Distribution Channel (USD Million)
      • India
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Drug Type (USD Million)
        • Market Size & Forecast, By Distribution Channel (USD Million)
      • Rest of Asia Pacific
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Drug Type (USD Million)
        • Market Size & Forecast, By Distribution Channel (USDecast (2023-2030), USD Million
          • Market Size & Forecast, By Type (USD Million)
          • Market Size & Forecast, By Product (USD Million)
          • Market Size & Forecast, By Drug Type (USD Million)
          • Market Size & Forecast, By Distribution Channel (USD Million)
        • Middle East & Africa (MEA) Premenstrual Syndrome Treatment Market Size & Forecast (2023-2030), USD Million
          • Market Size & Forecast, By Type (USD Million)
          • Market Size & Forecast, By Product (USD Million)
          • Market Size & Forecast, By Drug Type (USD Million)
          • Market Size & Forecast, By Distribution Channel (USD Million)
      • Competitive Landscape
        • Key Players and their Competitive Positioning
          • Key Player Comparison
          • Segment-wise Player Mapping
          • Market Share Analysis (2024)
          • Compali>Emerging Players
          • Innovative Players
      • Key Strategies Assessment, By Player (2022-2024)
        • New Product Launches
        • Partnerships, Agreements, & Collaborations
        • Mergers & Acquisitions
        • Geographic Expansion
    • Company Profiles*(Business Overview, Financial Performance**, Products Offered, Recent Developments)
      • Herbalife International of America, Inc.
      • Pharmavite LLC
      • Natures Bounty
      • Amway
      • GNC Holdings, Inc.
      • USANA Health Sciences, Inc.
      • GlaxoSmithKline Plc
      • RBK Nutraceuticals Pty Ltd.
      • Archer Daniels Midland
      • Power Gummies
      • Looni
      • Other Prominent Players

    Note: *Indicative list

    **For li